Efficacy Study of LY2422347 to Treat Insomnia

NCT00259311 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep Initiation and Maintenance Disorders

Interventions

DRUG: LY2422347
DRUG: placebo

Sponsor

Eli Lilly and Company